Corporate Presentation

Rare Diseases We aspire to lead in SBS and CHI, and expand into intestinal rehabilitation and transient hyperinsulinism to alleviate disease burden for as many patients as possible Corporate Presentation ZEAL & ZEALAND PHARMA 33

View entire presentation